OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Future Perspectives of Pulmonary Hypertension Treatment.
Chih‐Hsin Hsu, Wei‐Chun Huang, Wei‐Ting Chang
PubMed (2022) Vol. 38, Iss. 4, pp. 435-442
Closed Access | Times Cited: 8
Chih‐Hsin Hsu, Wei‐Chun Huang, Wei‐Ting Chang
PubMed (2022) Vol. 38, Iss. 4, pp. 435-442
Closed Access | Times Cited: 8
Showing 8 citing articles:
New Drugs and Therapies in Pulmonary Arterial Hypertension
Aangi J. Shah, Taylor Beckmann, Mounica Vorla, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 6, pp. 5850-5850
Open Access | Times Cited: 35
Aangi J. Shah, Taylor Beckmann, Mounica Vorla, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 6, pp. 5850-5850
Open Access | Times Cited: 35
Pulmonary vascular fibrosis in pulmonary hypertension – The role of the extracellular matrix as a therapeutic target
Katharina Jandl, Nemanja Radic, Katarina Zeder, et al.
Pharmacology & Therapeutics (2023) Vol. 247, pp. 108438-108438
Closed Access | Times Cited: 23
Katharina Jandl, Nemanja Radic, Katarina Zeder, et al.
Pharmacology & Therapeutics (2023) Vol. 247, pp. 108438-108438
Closed Access | Times Cited: 23
Pulmonary Hypertension Associated with Interstitial Lung Disease (PH-ILD): Back to the Future
Giordano Fiorentù, Nicol Bernardinello, G. Giulianelli, et al.
Advances in Therapy (2025)
Open Access | Times Cited: 1
Giordano Fiorentù, Nicol Bernardinello, G. Giulianelli, et al.
Advances in Therapy (2025)
Open Access | Times Cited: 1
MicroRNA and lncRNA as the Future of Pulmonary Arterial Hypertension Treatment
Łukasz Wołowiec, Martyna Mędlewska, Joanna Osiak, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 11, pp. 9735-9735
Open Access | Times Cited: 13
Łukasz Wołowiec, Martyna Mędlewska, Joanna Osiak, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 11, pp. 9735-9735
Open Access | Times Cited: 13
Use of Levosimendan in Patients with Pulmonary Hypertension: What is the Current Evidence?
Daniele Masarone, M. Kittleson, Piero Pollesello, et al.
Drugs (2023) Vol. 83, Iss. 3, pp. 195-201
Closed Access | Times Cited: 9
Daniele Masarone, M. Kittleson, Piero Pollesello, et al.
Drugs (2023) Vol. 83, Iss. 3, pp. 195-201
Closed Access | Times Cited: 9
Advances in the potential of nebulized inhalation for the treatment of pulmonary arterial hypertension
Miao Lu, Yang-Jin Baima, Ni Zhu, et al.
Current Problems in Cardiology (2024) Vol. 49, Iss. 10, pp. 102752-102752
Closed Access
Miao Lu, Yang-Jin Baima, Ni Zhu, et al.
Current Problems in Cardiology (2024) Vol. 49, Iss. 10, pp. 102752-102752
Closed Access
Pulmonary Hypertension, an Evolutional Disease with Multidisciplinary Team Management.
Yu‐Wei Chiu, Yen‐Wen Wu
PubMed (2023) Vol. 39, Iss. 2, pp. 209-212
Closed Access
Yu‐Wei Chiu, Yen‐Wen Wu
PubMed (2023) Vol. 39, Iss. 2, pp. 209-212
Closed Access
Pulse Wave Analysis Predicts Invasive Hemodynamics in Pre-Capillary Pulmonary Hypertension.
Yen‐Yu Liu, Shu‐Hao Wu, Cheng‐Ting Tsai, et al.
PubMed (2023) Vol. 39, Iss. 2, pp. 319-330
Closed Access
Yen‐Yu Liu, Shu‐Hao Wu, Cheng‐Ting Tsai, et al.
PubMed (2023) Vol. 39, Iss. 2, pp. 319-330
Closed Access
